United States

People: Accelerate Diagnostics Inc (AXDX.O)

AXDX.O on Consolidated Issue listed on NASDAQ Capital Market

23 Jun 2017
Change (% chg)

$-0.05 (-0.17%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Patience, John 

Mr. John Patience is Independent Chairman of the Board of Accelerate Diagnostics Inc. since June 26, 2012. Mr. Patience is also a founding partner of Crabtree Partners, a private equity investment firm. Mr. Patience served as a director of Ventana Medical Systems, Inc. from 1989 and as Vice Chairman from 1999 until Ventana’s acquisition by Roche in 2008. Mr. Patience has been a director of Stericycle, Inc. (NASDAQ: SRCL) since 1989. Mr. Patience was previously a partner of a venture capital investment firm that provided both Ventana and Stericycle with early stage funding. Mr. Patience was also previously a partner in the consulting firm of McKinsey & Co. Inc. specializing in health care. Mr. Patience holds a B.A. in Liberal Arts and an L.L.B. from the University of Sydney, Australia, and an M.B.A. from the University of Pennsylvania’s Wharton School of Business.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 79,519
Fiscal Year Total, USD 79,519

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --